Back to results
US 2026/0250652 A1Published application
Ph20 polypeptide variants, formulations and uses thereof
AssigneeHalozyme, Inc.
InventorsGe Wei, H. Michael Shepard, Qiping Zhao, Robert James Connor
Life of this patent
Estimating the term…
Abstract
PH20 hyaluronidase polypeptides, including modified polypeptides that exhibit increased stability and/or increased activity, are provided. Also provided are compositions and formulations and uses thereof.
Claims33
A polypeptide comprising:
- amino acids 38-468 of SEQ ID NO:
- 6,
- wherein the polypeptide does not comprise amino acids 1-37 of SEQ ID NO:
- 6,
- wherein the polypeptide does not comprise amino acids 469-509 of SEQ ID NO:
- 6, and
- wherein the polypeptide comprises at least one amino acid replacement located at amino acid position 38, 40, 43, 44, 46, 47, 49, 50, 51, 52, 53, 54, 55, 57, 58, 59, 61, 62, 63, 70, 71, 72, 74, 76, 77, 78, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 93, 95, 96, 97, 98, 99, 102, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 126, 128, 129, 131, 132, 133, 134, 135, 137, 140, 141, 173, 176, 177, 178, 180, 181, 182, 184, 185, 187, 188, 189, 191, 192, 193, 194, 195, 196, 197, 199, 200, 201, 202, 204, 236, 241, 243, 244, 250, 251, 252, 254, 255, 256, 257, 258, 259, 260, 262, 263, 264, 265, 266, 267, 269, 270, 272, 273, 274, 275, 276, 298, 300, 301, 302, 303, 304, 305, 306, 307, 308, 309, 311, 313, 315, 316, 322, 323, 325, 326, 329, 330, 331, 332, 333, 334, 335, 336, 337, 338, 341, 342, 343, 344, 345, 346, 347, 348, 349, 350, 352, 353, 354, 355, 356, 357, 358, 359, 360, 361, 362, 363, 364, 365, 366, 367, or any combination thereof, with reference to amino acids 38-468 of SEQ ID NO:
- 6.
5 more elements
2-6. (canceled)
(canceled)
(canceled)
Dependencies are inferred from the claim text.